Sun Pharmaceutical Industries Limited – NSE:SUNPHARMA.NS

Sun Pharmaceutical Industries Limited stock price today

INR 848.95
-1012.3
-54.39%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sun Pharmaceutical Industries Limited stock price monthly change

+18.00%
month

Sun Pharmaceutical Industries Limited stock price quarterly change

+18.00%
quarter

Sun Pharmaceutical Industries Limited stock price yearly change

+48.61%
year

Sun Pharmaceutical Industries Limited key metrics

Market Cap
 4.35T
Enterprise value
 4.41T
P/E
 40.30
EV/Sales
 8.80
EV/EBITDA
 28.22
Price/Sales
 8.91
Price/Book
 6.44
PEG ratio
 5.59
EPS
 39.94
Revenue
 479.28B
EBITDA
 137.04B
Income
 95.76B
Revenue Q/Q
 11.72%
Revenue Y/Y
 10.74%
Profit margin
 22.07%
Oper. margin
 23.43%
Gross margin
 60.77%
EBIT margin
 23.43%
EBITDA margin
 28.59%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sun Pharmaceutical Industries Limited stock price history

Sun Pharmaceutical Industries Limited stock forecast

Sun Pharmaceutical Industries Limited financial statements

Profit Margin

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Profit margin
Jun 2023 117.85B 20.22B 17.16%
Sep 2023 120.03B 23.75B 19.79%
Dec 2023 121.56B 25.23B 20.76%
Mar 2024 119.82B 26.54B 22.15%
SUNPHARMA.NS income statement history

Sun Pharmaceutical Industries Limited Financials Estimate

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Analyst Estimates
2026 589.73B 128.00B 21.71%
2027 627.51B 143.75B 22.91%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Quarterly Earnings

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Earnings per share (EPS)
2024-10-28 11.62 12.7
SUNPHARMA.NS earnings history
0.72%
Yield TTM
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Payout ratio
Payout ratio 0%
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Dividend Yield
2016 0.37%
2017 0.15%
2019 0.42%
2020 1.97%
2022 0.98%
SUNPHARMA.NS dividends history

Debt to Assets

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Debt to assets
Jun 2023 0 0
Sep 2023 794411600000 162.44B 20.45%
Dec 2023 0 0
Mar 2024 854628800000 183.56B 21.48%
SUNPHARMA.NS balance sheet history

Cash Flow

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Cash Flow
Jun 2023 13.02B 0 0
Sep 2023 12.65B 0 0
Dec 2023 12.44B 0 0
Mar 2024 0 0 0
SUNPHARMA.NS cash flow history

Sun Pharmaceutical Industries Limited alternative data

Sun Pharmaceutical Industries Limited
Employees

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA.NS): Employee count
Aug 2023 38,000
Sep 2023 41,000
Oct 2023 41,000
Nov 2023 41,000
Dec 2023 41,000
Jan 2024 41,000
Feb 2024 41,000
Mar 2024 41,000
Apr 2024 41,000
May 2024 41,000
Jun 2024 41,000
Jul 2024 41,000

Sun Pharmaceutical Industries Limited other data

Sun Pharmaceutical Industries Limited
Executives

Insider Compensation
Mr. Kalyanasundaram Subramanian (1954) Director of Corporation Devel. & Whole-time Director
 $65,380,000
Mr. Dilip Shantilal Shanghvi (1955) MD & Executive Director
 $46,050,000
Mr. Sailesh Trambaklal Desai (1954) Whole Time Director
 $16,820,000

Frequently Asked Questions (FAQ)

  • What's the price of Sun Pharmaceutical Industries Limited stock today?

    One share of Sun Pharmaceutical Industries Limited stock can currently be purchased for approximately $848.95.

  • When is Sun Pharmaceutical Industries Limited's next earnings date?

    Sun Pharmaceutical Industries Limited is estimated to report earnings on Monday, 27 Oct 2025.

  • Does Sun Pharmaceutical Industries Limited pay dividends?

    Yes, Sun Pharmaceutical Industries Limited pays dividends and its trailing 12-month yield is 0.73% with 0% payout ratio. The last Sun Pharmaceutical Industries Limited stock dividend of $0 was paid on 12 Sep 2025.

  • How much money does Sun Pharmaceutical Industries Limited make?

    Sun Pharmaceutical Industries Limited has a market capitalization of 4.35T and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.29% to 477.58B US dollars. Sun Pharmaceutical Industries Limited earned 95.76B US dollars in net income (profit) last year or $12.7 on an earnings per share basis.

  • What is Sun Pharmaceutical Industries Limited's stock symbol?

    Sun Pharmaceutical Industries Limited is traded on the NSE under the ticker symbol "SUNPHARMA.NS".

  • What is Sun Pharmaceutical Industries Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Sun Pharmaceutical Industries Limited?

    Shares of Sun Pharmaceutical Industries Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Sun Pharmaceutical Industries Limited's key executives?

    Sun Pharmaceutical Industries Limited's management team includes the following people:

    • Mr. Kalyanasundaram Subramanian Director of Corporation Devel. & Whole-time Director(age: 71, pay: $65,380,000)
    • Mr. Dilip Shantilal Shanghvi MD & Executive Director(age: 70, pay: $46,050,000)
    • Mr. Sailesh Trambaklal Desai Whole Time Director(age: 71, pay: $16,820,000)

  • How many employees does Sun Pharmaceutical Industries Limited have?

    As Jul 2024, Sun Pharmaceutical Industries Limited employs 41,000 workers.

  • When Sun Pharmaceutical Industries Limited went public?

    Sun Pharmaceutical Industries Limited is publicly traded company for more then 29 years since IPO on 1 Jan 1996.

  • What is Sun Pharmaceutical Industries Limited's official website?

    The official website for Sun Pharmaceutical Industries Limited is sunpharma.com.

  • How can i contact Sun Pharmaceutical Industries Limited?

    Sun Pharmaceutical Industries Limited can be reached via phone at +91 22 4324 4324.

Sun Pharmaceutical Industries Limited company profile:

Sun Pharmaceutical Industries Limited

sunpharma.com
Exchange:

NSE

Full time employees:

43,000

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

+91 22 4324 4324
Sun House
Mumbai, 400063

:
ISIN: INE044A01036
CUSIP: Y8523Y158